Skip to main content

Table 5 Defined Daily Dose (DDD/1000 patient) in Hospital A before and after initiation of AMS

From: Impact of antimicrobial stewardship on antibiogram, consumption and incidence of multi drug resistance

Class of antibiotics

DDD/1000 patient

P-value

2019

2020

FQ

33.7

30.6

0.556

Carbapenems

66.8

68.8

0.706

Piperacillin

82

62.5

0.814

Colistin

20.8

21.8

0.814

Cephalosporins

35.5

32.8

0.58

Anti-MRSA

58

50.7

0.045

  1. MRSA methicillin-resistant Staphylococcus aureus, FQ fluoroquinolones, DDD Defined Daily Dose
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us